
NephLong
Tetrazin
Details
12.5 mg
25 mg
Generic Name: Tetrabenazine
Product Description:
Tetrazin Tablet contains Tetrabenazine, a vesicular monoamine transporter 2 (VMAT2) inhibitor used primarily for the treatment of movement disorders such as chorea associated with Huntington's disease and other hyperkinetic movement disorders (e.g., tardive dyskinesia, Tourette syndrome, dystonia).
-
Strengths Available: 12.5 mg, 25 mg
-
Dosage Form: Oral tablet
-
Mechanism of Action: Tetrabenazine works by depleting monoamines (dopamine, serotonin, norepinephrine, histamine) from nerve terminals, reducing involuntary movements.
Indications:
-
Chorea in Huntington’s disease
-
Tics in Tourette syndrome (off-label)
-
Tardive dyskinesia (off-label)
Common Side Effects:
-
Drowsiness
-
Depression
-
Insomnia
-
Fatigue
-
Parkinsonism (tremor, rigidity)
Caution: Use with caution in patients with a history of depression or suicidal ideation. Dose adjustment may be required in hepatic impairment.
Keto Nephron™ DS is a Medical Food as defined under 21 U.S.C. §360ee(b)(3) and 21 CFR 101.9(j)(8), formulated for the dietary management of Chronic Kidney Disease (CKD) Stages 3-5 in adults following physician-supervised protein-restricted diets. It is not a drug, not a dietary supplement, and is not intended for self-medication or general wellness use. MUST BE USED UNDER MEDICAL SUPERVISION. Quantum LifeSciences Inc., Claremont, CA 91711, USA. FDA Food Facility (Manufacturer) Reg. No. 14961463490.